Evogene

Rehovot, Israel Founded: 2002 • Age: 24 yrs
Developer of plant traits
Request Access

About Evogene

Evogene is a company based in Rehovot (Israel) founded in 2002.. The company has 117 employees as of December 31, 2024. Evogene offers products and services including CPB Platform, MicroBoost, ChemPass, and GeneRator. Evogene operates in a competitive market with competitors including Benson Hill, Cibus, Ceres, Limagrain and Pairwise, among others.

  • Headquarter Rehovot, Israel
  • Employees 117 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Evogene Ltd.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Agriculture → Agricultural Technology & Innovation
Key Metrics
  • Annual Revenue
    $8.51 M
    50.9
    as on Dec 31, 2024
  • Net Profit
    $-16.49 M
    30.96
    as on Dec 31, 2024
  • EBITDA
    $-19.23 M
    19.13
    as on Dec 31, 2024
  • Latest Funding Round
    $1.32 M (USD), Grant

    May 09, 2023

  • Investors
  • Employee Count
    117

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Evogene

Evogene is a publicly listed company on the NASDAQ with ticker symbol EVGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: EVGN . Sector: Health technology · USA

Products & Services of Evogene

Evogene offers a comprehensive portfolio of products and services, including CPB Platform, MicroBoost, ChemPass, and GeneRator. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Integrates AI and big data for predictive biology in product development.

Facilitates discovery of microbe-based life-science products.

Enables development of small molecule-based innovations.

Supports genetic element-based product creation.

People of Evogene
Headcount 50-200
Employee Profiles 29
Board Members and Advisors 8
Employee Profiles
People
Ofer Haviv
President and Chief Executive Officer
People
Liat Foigel Wejgman
Vice President, Human Resources
People
Eyal Ronen
Executive Vice President, Business Development
People
Tal Katz
VP Operations

Unlock access to complete

Board Members and Advisors
people
Nir Nimrodi
Chairman Of The Board

Unlock access to complete

Funding Insights of Evogene

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $1.3M
  • First Round

    (30 Apr 2008)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Grant - Evogene Valuation

investors

May, 2023 Amount Grant - Evogene Valuation

investors

Jan, 2016 Amount Grant - Evogene Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Evogene

Evogene has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and AquAgro Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Evogene

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Evogene

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Evogene Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Evogene

Evogene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benson Hill, Cibus, Ceres, Limagrain and Pairwise, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of plant-based food ingredients
domain founded_year HQ Location
Gene editing solutions are provided for agriculture.
domain founded_year HQ Location
Beers are produced and branded by Ceres in Italy.
domain founded_year HQ Location
Production and distribution of GM and non-GMO seeds and other farm inputs
domain founded_year HQ Location
New crop varieties are developed using gene-editing for agrigenomics.
domain founded_year HQ Location
Breeding technology is provided by Inari to design seeds.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Evogene

When was Evogene founded?

Evogene was founded in 2002 and raised its 1st funding round 6 years after it was founded.

Where is Evogene located?

Evogene is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.

How many employees does Evogene have?

As of Dec 31, 2024, the latest employee count at Evogene is 117.

What is the annual revenue of Evogene?

Annual revenue of Evogene is $8.51M as on Dec 31, 2024.

What does Evogene do?

Evogene was founded in 2002 in Rehovot, Israel, within the agrotechnology sector. Plant traits aimed at improving yield and drought tolerance in key crops are developed through plant genomics. Proprietary computational genomic technologies are employed to deliver solutions for trait enhancement, integrating biotechnology with advanced breeding techniques. Operations focus on a range of essential crops to support agricultural improvements.

Who are the top competitors of Evogene?

Evogene's top competitors include Benson Hill, Cibus and Inari.

What products or services does Evogene offer?

Evogene offers CPB Platform, MicroBoost, ChemPass, and GeneRator.

Is Evogene publicly traded?

Yes, Evogene is publicly traded on NASDAQ under the ticker symbol EVGN.

Who are Evogene's investors?

Evogene has 2 investors. Key investors include European Union, and AquAgro Fund.

What is Evogene's ticker symbol?

The ticker symbol of Evogene is EVGN on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available